ArticleEnvironment & health (Washington, D.C.)2026
Antiviral Drugs in Wastewater-Based Epidemiology for Epidemic Surveillance and Alerting.
Article in Environment & health (Washington, D.C.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Wastewater-Based Epidemiology (WBE) has provided critical surveillance and alerting during epidemic outbreaks such as COVID-19 through viral nucleic acid detection, yet it faces limitations including a narrow short detection time window and the potential for viral variants to escape. The high global incidence of viral diseases has driven increased consumption of antiviral drugs (AVDs). Serving as direct chemical signatures of diagnosis and treatment behaviors, AVDs offer new indicators for epidemic Surveillance and Alerting. This paper systematically outlines the scientific basis for applying AVDs in WBE-based alerting, analyzes core challenges such as data availability, target biomarker selection, and methodological standardization, and proposes a pathway of "Biomarker Validation-Technical Standard Harmonization -Methodologies Optimizing -Global Network Building". This AVD-based WBE supports improving epidemic surveillance and alerting system.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.